Having recently shown that Ybx3-deficient mice are protected in animal models of kidney disease [12,13], it now remains to be determined to what extent extracellular DbpA contributes to disease activity and whether targeting extracellular DbpA may be a means to slow the development of fibrosis and thereby prolong kidney function. The gene discussed is YBX3; the disease is kidney disorder.